Navigation Links
Next Inning Technology Research Identifies Winning Option Writing Strategies on Undervalued Stocks
Date:3/11/2009

n an opportunity to "harvest" a premium by writing options in high quality stable companies with limited downside risk to intrinsic value. Next Inning has applied this approach to the technology sector in the past with success, has recently identified several new ideas, and will publish a several more taking advantage of these anomalies.

McWilliams also looks at these topics:

-- Why does McWilliams think the price of DNP is artificially depressed? Does he think the 12%+ dividend is safe?

-- How can investors lock in returns greater than 20% with Pfizer and, at the same time, drop their risk exposure below what it would be if they just held the stock?

-- What strategy can investors use to lock in a 28% return with a very low risk exposure in the Tech sector?

-- Why does McWilliams think Analog Devices is destined to beat its guidance this quarter? How can investors lock in a 41% total return with Analog Devices, yet expose themselves to less risk than a typical Analog Devices shareholder?

Founded in September 2002, Next Inning's model portfolio has returned 118% since its inception versus 5% for the Nasdaq.

About Next Inning:

Next Inning is a subscription financial newsletter focused on technology stocks. Editor Paul McWilliams is a 20+-year semiconductor industry veteran.

NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926. Interested parties may visit adviserinfo.sec.gov for additional information. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

CONTACT: Marcia Martin Next Inning Technology Research, +1-888-278-5515


'/>"/>
SOURCE Indie Research Advisors, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Olympic Gold Winning Supplement Lands in the US
2. Award Winning Photographer and Museum Founder to Donate Iconic Images In Support of the Innocence Project
3. Inspired Cancer Survivor Launches Customized Hair Replacement Techniques at Award-Winning Hair Salon
4. MidMichigan Health Cuts Out Trans Fats Beginning March 1
5. Disability Community Humble Beginnings Lead to Great Things at Disabled World
6. Governor Crist Proclaims Tobacco Free Florida Week Beginning February 27
7. Icagen Board Beginning to Follow Xmark Direction
8. A Newly Approved CMS Medicare Package Expands Reimbursement Coverage for Telehealth Originating Sites Beginning January 1, 2009
9. Pennsylvania to Offer Free Nicotine Replacement Therapy Kits Beginning Feb. 2
10. Author Shares Nine Resolutions for 2009 to Create a Winning Corporate Culture
11. Cadient Group Expands Award-Winning Capabilities with Key New Hires
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... Garden State ... 2008, the result of a merger of five of the busiest urology practices ... could provide more cost-effective and higher quality care than they did individually. ...
(Date:8/31/2015)... ... ... Top Docs Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed and approved as ... graduated from Don Bosco Prep in 1990 and was Class Salutatorian. He earned Varsity ... his senior year. He was inducted into the National Honor Society as a sophomore, ...
(Date:8/31/2015)... ... ... Dr. Stewart Shofner of Shofner Vision Center explains what causes ... comprehensive eye examination can diagnose amblyopia. According to the National Eye Institute ... 2 to 3 out of every 100 children. , Dr. Shofner adds, “unless ...
(Date:8/31/2015)... Creek, CA (PRWEB) , ... August 31, 2015 ... ... national print and digital marketing communications company announced today that it has officially ... Fonzi, DP President, the new website and brand refresh are more closely aligned ...
(Date:8/31/2015)... ... August 31, 2015 , ... Three Bakers Gluten Free Bakery launched the redesign ... relevant and easy-to-find information on their offering of gluten-free breads and pizzas, living without ... important way for us to share information about our gluten free product offerings, but ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Garden State Urology! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Three Bakers Gluten Free Bakery Announces Launch of New Website 2
... Global Breast ... Cancer Incidence, Mortality Rates, WASHINGTON, March 12 First ... for the Cure (R) Global Promise Fund at a,Capitol Hill ... its new strategy of funding culturally sensitive,sustainable education and outreach ...
... - Completed LogistiCare acquisition ... - Vanderbilt study released showing 81% success rate - Fourth ... and $6 million from social services ... segment, - Fourth quarter diluted earnings per share of $0.35, ...
... March 12 The following was,issued today by ... Forum (NQF) Implementation Conference on Care,Coordination and 2008 ... http://www.qualityforum.org ., March 26: Spring Membership ... NQF membership and leaders of the National Priorities,Partners, ...
... use ibuprofen for arthritis pain or other conditions while ... stroke undermine aspirins ability to act as an anti-platelet ... , In a cohort of patients seen by physicians ... patients were identified as taking both aspirin and ibuprofen ...
... Significantly Impact Patient Health and Financial ... Performance of Pharmaceutical Companies, NEW YORK and LONDON, ... billion per year and causing an,estimated 125,000 deaths per year ... the healthcare industry. Eularis has,responded to this problem with a ...
... finding shouldn,t keep physicians from using Avastin, researchers say , , ... drug Avastin can cause kidney damage by doing what it,s ... shows. , Avastin, whose generic name is bevacizumab, is the ... cancers by cutting off their blood supply. It does this ...
Cached Medicine News:Health News:First Lady Laura Bush Joins Susan G. Komen for the Cure (R) to Launch Global Promise Fund Assisting Women Worldwide 2Health News:First Lady Laura Bush Joins Susan G. Komen for the Cure (R) to Launch Global Promise Fund Assisting Women Worldwide 3Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 2Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 3Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 4Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 5Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 6Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 7Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 8Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 9Health News:Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance 10Health News:National Quality Forum Spring Conference; Leaders in Healthcare Quality to Focus on National Priorities and Care Coordination 2Health News:Ibuprofen destroys aspirin's positive effect on stroke risk 2Health News:Ibuprofen destroys aspirin's positive effect on stroke risk 3Health News:Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report 2Health News:Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report 3Health News:Doctors See How Cancer Drug Can Damage Kidneys 2Health News:Doctors See How Cancer Drug Can Damage Kidneys 3
(Date:8/31/2015)... , Aug. 31, 2015  Qualcomm Incorporated (NASDAQ: ... Qualcomm Life, Inc., is collaborating with ... care management solutions powered by Qualcomm Life,s 2net™ ... to enable continuous care, informed interventions and better ... at Qualcomm Life,s annual Connect 2015 ...
(Date:8/31/2015)... STAMFORD, Conn. , Aug. 31, 2015 ... Co., Ltd., and Purdue Pharma L.P. announced today that ... the development and commercialization of Eisai,s clinical candidate lemborexant ... Phase III clinical development for the treatment of insomnia. ... Eisai and Purdue Pharma will share the costs of ...
(Date:8/30/2015)... Switzerland , August 31, 2015 ... healthbank to deliver ... , the world,s first citizen-owned health data transaction platform, ... and Netcetera to engineer and bring to ...      (Logo: http://photos.prnewswire.com/prnh/20150828/261966) , "Our business model ...
Breaking Medicine Technology:Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 2healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 3healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 4
... 31 Gen-Probe Incorporated,(Nasdaq: GPRO ) announced ... U.S.,clinical trial of its investigational APTIMA(R) assay to ... "Starting this highly complex, multi-center study was an ... Hull, the Company,s president and,chief operating officer. "Enrolling ...
... Three Key Lipids and Had ... CHICAGO, March 31 New data from ... multiple lipid problems, Abbott,s,ABT-335 combined with two commonly ... lipids -- LDL "bad",cholesterol, triglycerides and HDL "good" ...
Cached Medicine Technology:Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 2Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 3Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 4Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 5Abbott's Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL 2Abbott's Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL 3
For the qualitative detection of human Chorionic Gonadotrophin (HCG) in urine or urine and serum specimens...
ZyDoc offers a full medical transcription and documentation solution....
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: